{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:32:36Z","timestamp":1792297956060,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,22]]},"DOI":"10.7759\/cureus.77804","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T08:34:41Z","timestamp":1737534881000},"source":"Crossref","is-referenced-by-count":11,"title":["Biologic Treatments for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): A Comparative Review of Efficiency and Risks"],"prefix":"10.7759","author":[{"given":"Mihai I","family":"T\u0103nase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Tanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Cosgarea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe Doinel","family":"Radeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Septimiu Sever","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma A","family":"Maniu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens WJ","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al.. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020, 58:1-464. 10.4193\/Rhin20.600","journal-title":"Rhinology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.32002","article-title":"In reference to clinical effects and response time of biological drugs in chronic rhinosinusitis with nasal polyps patients: real-life experience","author":"Orlando P","year":"2025","unstructured":"Orlando P, Gallo O. In reference to clinical effects and response time of biological drugs in chronic rhinosinusitis with nasal polyps patients: real-life experience. Laryngoscope. 2025, 10.1002\/lary.32002","journal-title":"Laryngoscope"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60121996","article-title":"Real-world evaluation of dupilumab in the long-term management of eosinophilic chronic rhinosinusitis with nasal polyps: a focus on IL-4 and IL-13 receptor blockade","volume":"60","author":"Lombardo N","year":"2024","unstructured":"Lombardo N, D'Ecclesia A, Chiarella E, et al.. Real-world evaluation of dupilumab in the long-term management of eosinophilic chronic rhinosinusitis with nasal polyps: a focus on IL-4 and IL-13 receptor blockade. Medicina (Kaunas). 2024, 60:10.3390\/medicina60121996","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23523","article-title":"Postoperative adjuvant dupilumab improved immediate recovery in patients with advanced type 2 chronic rhinosinusitis: an exploratory pilot study","author":"Ho YT","year":"2025","unstructured":"Ho YT, Wang HS, Lee TJ, Chang PH, Wu CC, Fu CH. Postoperative adjuvant dupilumab improved immediate recovery in patients with advanced type 2 chronic rhinosinusitis: an exploratory pilot study. Int Forum Allergy Rhinol. 2025, 10.1002\/alr.23523","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S478040","article-title":"Effect of dupilumab on Radiological remission in patients with chronic rhinosinusitis with nasal polyp: a one step forward toward clinical remission","volume":"17","author":"Al-Ahmad M","year":"2024","unstructured":"Al-Ahmad M, Ali A, Dawood HA, Beshreda GM. Effect of dupilumab on Radiological remission in patients with chronic rhinosinusitis with nasal polyp: a one step forward toward clinical remission. J Asthma Allergy. 2024, 17:1027-40. 10.2147\/JAA.S478040","journal-title":"J Asthma Allergy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21053\/ceo.2024.00233","article-title":"Therapeutic effectiveness of SNOT 22-based interdose interval adjustment of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"17","author":"Yoon SY","year":"2024","unstructured":"Yoon SY, Cha H, Hong SN, Yang MS, Kim DW. Therapeutic effectiveness of SNOT 22-based interdose interval adjustment of dupilumab for chronic rhinosinusitis with nasal polyps. Clin Exp Otorhinolaryngol. 2024, 17:317-25. 10.21053\/ceo.2024.00233","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/lary.31948","article-title":"Clinical effects and response time of biological drugs in chronic rhinosinusitis with nasal polyps patients: real-life experience","author":"De Santis S","year":"2024","unstructured":"De Santis S, Galassi S, Cambi J. Clinical effects and response time of biological drugs in chronic rhinosinusitis with nasal polyps patients: real-life experience. Laryngoscope. 2024, 10.1002\/lary.31948","journal-title":"Laryngoscope"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2024.104517","article-title":"Adverse events of mepolizumab in the treatment of nasal polyps: a FDA database evaluation","volume":"46","author":"Stephanian B","year":"2024","unstructured":"Stephanian B, Liu K, Salazar AM, Saba E, Liang J. Adverse events of mepolizumab in the treatment of nasal polyps: a FDA database evaluation. Am J Otolaryngol. 2024, 46:104517. 10.1016\/j.amjoto.2024.104517","journal-title":"Am J Otolaryngol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60701","article-title":"The rare adverse effect of myalgia after dupilumab biologic therapy for refractory atopic dermatitis","volume":"16","author":"Cochran BL","year":"2024","unstructured":"Cochran BL, Raymond-Lezman JR, Coican A, Sagasser N, Patel R, Batrous S, Greenfield MF. The rare adverse effect of myalgia after dupilumab biologic therapy for refractory atopic dermatitis. Cureus. 2024, 16:e60701. 10.7759\/cureus.60701","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.10.016","article-title":"Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR)","author":"Seys SF","year":"2024","unstructured":"Seys SF, Schneider S, de Kinderen J, et al.. Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR). J Allergy Clin Immunol. 2024, 10.1016\/j.jaci.2024.10.016","journal-title":"J Allergy Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-024-08903-7","article-title":"Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis","author":"Wang H","year":"2024","unstructured":"Wang H, Xu X, Lu Z, Zhai Z, Shao L, Song X, Zhang Y. Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis. Eur Arch Otorhinolaryngol. 2024, 10.1007\/s00405-024-08903-7","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2024.1428074","article-title":"Cross-border collaboration, communication, and research frontiers on biologics in chronic rhinosinusitis from 2004 to 2023","volume":"7","author":"Huang GJ","year":"2024","unstructured":"Huang GJ, Fan ZJ, Lu BQ. Cross-border collaboration, communication, and research frontiers on biologics in chronic rhinosinusitis from 2004 to 2023. Front Big Data. 2024, 7:1428074. 10.3389\/fdata.2024.1428074","journal-title":"Front Big Data"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16111370","article-title":"Investigation of blood count-based inflammatory biomarkers as predictors of response to dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps","volume":"16","author":"Habenbacher M","year":"2024","unstructured":"Habenbacher M, Moser U, Abaira A, et al.. Investigation of blood count-based inflammatory biomarkers as predictors of response to dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps. Pharmaceutics. 2024, 16:1370. 10.3390\/pharmaceutics16111370","journal-title":"Pharmaceutics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin24.337","article-title":"Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma","author":"Mullol J","year":"2024","unstructured":"Mullol J, Backer V, Constantinidis J, et al.. Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma. Rhinology. 2024, 10.4193\/Rhin24.337","journal-title":"Rhinology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.09.015","article-title":"Dupilumab versus mepolizumab for chronic rhinosinusitis with nasal polyposis: an indirect treatment comparison","volume":"12","author":"Hopkins C","year":"2024","unstructured":"Hopkins C, Han JK, Fokkens W, et al.. Dupilumab versus mepolizumab for chronic rhinosinusitis with nasal polyposis: an indirect treatment comparison. J Allergy Clin Immunol Pract. 2024, 12:3393-401.e15. 10.1016\/j.jaip.2024.09.015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin24.284","article-title":"Responders to biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a multicentric observational real-life study","author":"Mortuaire G","year":"2024","unstructured":"Mortuaire G, B\u00e9quignon E, Daveau C, et al.. Responders to biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a multicentric observational real-life study. Rhinology. 2024, 10.4193\/Rhin24.284","journal-title":"Rhinology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v23i3.15635","article-title":"The efficacy of omalizumab in patients with chronic rhinosinusitis with nasal polyps and comorbid severe allergic asthma","volume":"23","author":"Atayik E","year":"2024","unstructured":"Atayik E, Aytekin G, Aydin \u0130, Omeroglu E. The efficacy of omalizumab in patients with chronic rhinosinusitis with nasal polyps and comorbid severe allergic asthma. Iran J Allergy Asthma Immunol. 2024, 23:245-56. 10.18502\/ijaai.v23i3.15635","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.10.007","article-title":"Optimization of clinical biological therapies for chronic rhinosinusitis with nasal polyps","volume":"12","author":"Xian M","year":"2024","unstructured":"Xian M, Zhang L. Optimization of clinical biological therapies for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2024, 12:3402-3. 10.1016\/j.jaip.2024.10.007","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-11-23-7032","article-title":"Updates in the management of chronic rhinosinusitis","volume":"53","author":"Webb H","year":"2024","unstructured":"Webb H, Morcom S. Updates in the management of chronic rhinosinusitis. Aust J Gen Pract. 2024, 53:928-31. 10.31128\/AJGP-11-23-7032","journal-title":"Aust J Gen Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.70010","article-title":"Chronic rhinosinusitis with nasal polyps: key considerations in the multidisciplinary team approach","volume":"15","author":"Pfaar O","year":"2025","unstructured":"Pfaar O, Peters AT, Taill\u00e9 C, Teeling T, Silver J, Chan R, Hellings PW. Chronic rhinosinusitis with nasal polyps: key considerations in the multidisciplinary team approach. Clin Transl Allergy. 2025, 15:e70010. 10.1002\/clt2.70010","journal-title":"Clin Transl Allergy"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/AMEP.S406537","article-title":"Can non-virtual reality simulation improve surgical training in endoscopic sinus surgery? A literature review","volume":"14","author":"Stan C","year":"2023","unstructured":"Stan C, Vesa D, T\u0103nase MI, et al.. Can non-virtual reality simulation improve surgical training in endoscopic sinus surgery? A literature review. Adv Med Educ Pract. 2023, 14:637-46. 10.2147\/AMEP.S406537","journal-title":"Adv Med Educ Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53529","article-title":"Exploring the ovine anatomy: a comprehensive study of the sheep\u2019s head for basic training in functional endoscopic sinus surgery","volume":"16","author":"Stan C","year":"2024","unstructured":"Stan C, Blebea C, T\u0103nase MI, et al.. Exploring the ovine anatomy: a comprehensive study of the sheep\u2019s head for basic training in functional endoscopic sinus surgery. Cureus. 2024, 16:e53529. 10.7759\/cureus.53529","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23498","article-title":"Methodological limitations in the systematic review of rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis","volume":"15","author":"Moreno-Pe\u00f1a PJ","year":"2025","unstructured":"Moreno-Pe\u00f1a PJ, \u00c1lvarez-Villalobos NA, Trevi\u00f1o-Gonz\u00e1lez JL. Methodological limitations in the systematic review of rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2025, 15:95-6. 10.1002\/alr.23498","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59725","article-title":"Hand motion analysis using accelerometer-based sensors and sheep\u2019s head model for basic training in functional endoscopic sinus surgery","volume":"16","author":"Stan C","year":"2024","unstructured":"Stan C, Ujvary PL, Blebea C, et al.. Hand motion analysis using accelerometer-based sensors and sheep\u2019s head model for basic training in functional endoscopic sinus surgery. Cureus. 2024, 16:e59725. 10.7759\/cureus.59725","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226883","article-title":"Monoclonal antibody switching in biologic treatment of chronic rhinosinusitis with nasal polyps","volume":"13","author":"Habenbacher M","year":"2024","unstructured":"Habenbacher M, Moser U, Hadl O, et al.. Monoclonal antibody switching in biologic treatment of chronic rhinosinusitis with nasal polyps. J Clin Med. 2024, 13:10.3390\/jcm13226883","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101792","article-title":"Sheep\u2019s head as an anatomic model for basic training in endoscopic sinus surgery","volume":"59","author":"Stan C","year":"2023","unstructured":"Stan C, Ujvary LP, Blebea CM, et al.. Sheep\u2019s head as an anatomic model for basic training in endoscopic sinus surgery. Medicina (Kaunas). 2023, 59:10.3390\/medicina59101792","journal-title":"Medicina (Kaunas)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/19458924241298817","article-title":"Dupilumab treatment for aspirin-exacerbated respiratory disease in a real-world setting: impact on quality of life and healthcare utilization","author":"Mullur J","year":"2024","unstructured":"Mullur J, Maurer R, Ryan T, McGill A, Bensko JC, Laidlaw TM, Buchheit KM. Dupilumab treatment for aspirin-exacerbated respiratory disease in a real-world setting: impact on quality of life and healthcare utilization. Am J Rhinol Allergy. 2024, 19458924241298817. 10.1177\/19458924241298817","journal-title":"Am J Rhinol Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336028-biologic-treatments-for-chronic-rhinosinusitis-with-nasal-polyps-crswnp-a-comparative-review-of-efficiency-and-risks","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T08:34:43Z","timestamp":1737534883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336028-biologic-treatments-for-chronic-rhinosinusitis-with-nasal-polyps-crswnp-a-comparative-review-of-efficiency-and-risks"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.77804","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}